In 2022, GSK’s 12 manufacturing sites in eight countries produced and delivered more than 500 million vaccine doses—one and a half million vaccine doses daily. Each year, about 40% of the ...
Working out of 12 manufacturing sites, the company distributed 767 million vaccine doses across more than 160 countries in 2021. More than ten million people received one of GSK’s meningococcal ...
The proposals would see the Ulverston site become ... science and manufacturing hub in Cumbria has been unveiled. The site at Ulverston currently belongs to GlaxoSmithKline (GSK), which is winding ...